Inhibition of lymphokine-activated killer cell generation by blocking factors in sera of patients with head and neck cancer

1990 ◽  
Vol 31 (3) ◽  
pp. 176-181 ◽  
Author(s):  
Samuel P. Bugis ◽  
Eva Lotzová ◽  
Howard E. Savage ◽  
Jeane P. Hester ◽  
Tamas Racz ◽  
...  
1985 ◽  
Vol 95 (5) ◽  
pp. 588???594 ◽  
Author(s):  
Stimson P. Schantz ◽  
Marvin M. Romsdahl ◽  
Kenji Nishioka ◽  
George F. Babcock ◽  
Helmuth Goepfert

Head & Neck ◽  
2012 ◽  
Vol 35 (3) ◽  
pp. 388-398 ◽  
Author(s):  
Dejan Baskic ◽  
Lazar Vujanovic ◽  
Nebojsa Arsenijevic ◽  
Theresa L. Whiteside ◽  
Eugene N. Myers ◽  
...  

Surgery ◽  
2012 ◽  
Vol 152 (3) ◽  
pp. 431-440 ◽  
Author(s):  
Eric Luedke ◽  
Alena Cristina Jaime-Ramirez ◽  
Neela Bhave ◽  
Julie Roda ◽  
Moaz Maqbool Choudhary ◽  
...  

1978 ◽  
Vol 86 (3) ◽  
pp. ORL-428-ORL-432 ◽  
Author(s):  
Peter E. Maxim ◽  
Robert W. Veltri ◽  
Philip M. Sprinkle ◽  
Robert J. Pusateri

With the recent demonstrations of circulating immune complexes in a variety of malignant and nonmalignant diseases, we have examined the sera of head and neck cancer patients for evidence of soluble immune complexes. Using the Raji cell test, we have shown that immune complexes are present in over 80% of the cancer sera examined as compared to less than 10% of normal control sera, and that these complexes persist following treatment of the patients by surgery or radiation therapy. These complexes may be acting as blocking factors which would account for the anergic state of these patients.


2000 ◽  
Vol 11 (3) ◽  
pp. 165-173 ◽  
Author(s):  
Masato Okamoto ◽  
Go Ohe ◽  
Tetsuya Oshikawa ◽  
Hidetomo Nishikawa ◽  
Sachiko Furuichi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document